Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study

To evaluate the effect of peri‐operative blood transfusion (PBT) on recurrence‐free survival, overall survival, cancer‐specific mortality and other‐cause mortality in patients undergoing radical cystectomy (RC), using a contemporary European multicentre cohort.

[1]  H. Marret,et al.  Low body mass index is an independent predictive factor of local recurrence after conservative treatment for breast cancer , 2001, Breast Cancer Research and Treatment.

[2]  H. S. Kim,et al.  The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy , 2015, Korean journal of urology.

[3]  U. Gunnarsson,et al.  The Importance of Blood Loss During Colon Cancer Surgery for Long-Term Survival: An Epidemiological Study Based on a Population Based Register , 2012, Annals of surgery.

[4]  E. Vamvakas,et al.  Transfusion-related immunomodulation (TRIM): an update. , 2007, Blood reviews.

[5]  T. Clozel,et al.  Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. , 2012, European urology.

[6]  K. Delman,et al.  Effects of Perioperative Red Blood Cell Transfusion on Disease Recurrence and Survival After Pancreaticoduodenectomy for Ductal Adenocarcinoma , 2011, Annals of Surgical Oncology.

[7]  E. Vamvakas,et al.  Transfusion‐associated cancer recurrence and postoperative infection: meta‐analysis of randomized, controlled clinical trials , 1996, Transfusion.

[8]  J. Cheville,et al.  The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. , 2013, European urology.

[9]  M. Wirth,et al.  Perioperative complications of radical cystectomy in a contemporary series. , 2007, European urology.

[10]  S. Phillips,et al.  The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. , 2013, Urologic oncology.

[11]  U. Metzger,et al.  Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer , 2003, The British journal of surgery.

[12]  F. Saad,et al.  Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy , 2007, BJU international.

[13]  J. Cheville,et al.  Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality , 2014, Cancer.

[14]  R. Thompson,et al.  Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? , 2014, European urology.

[15]  R. Sylvester,et al.  Re: Shahrokh F. Shariat, Behfar Ehdaie, Michael Rink, et al. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur urol 2012;61:237-42. , 2012, European urology.

[16]  W. Ross.  Blood transfusions and prognosis in colorectal cancer. , 1993, The New England journal of medicine.

[17]  S. Byun,et al.  Association between Perioperative Blood Transfusion and Oncologic Outcomes after Curative Surgery for Renal Cell Carcinoma , 2016, Journal of Cancer.

[18]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[19]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[20]  D. Schroeder,et al.  Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy , 2014, Transfusion.

[21]  B. Trock,et al.  Allogeneic versus autologous blood transfusion and survival after radical prostatectomy (CME) , 2014, Transfusion.

[22]  임재영,et al.  BMI(Body Mass Index)가 소득에 미치는 영향 , 2012 .

[23]  F. Schildberg,et al.  Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Francis,et al.  BLOOD TRANSFUSION AND TUMOUR GROWTH: EVIDENCE FROM LABORATORY ANIMALS , 1981, The Lancet.

[25]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[26]  M Baum,et al.  The effects of surgery on tumor growth: a century of investigations. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  B. Konety,et al.  Effect of perioperative blood transfusion on mortality for major urologic malignancies. , 2015, Clinical genitourinary cancer.

[28]  E. Vamvakas.  Allogeneic blood transfusion and cancer recurrence: 20 years later , 2014, Transfusion.

[29]  M. Fiorotto,et al.  OEDEMA OF MALNUTRITION , 1982, The Lancet.

[30]  F. Liedberg.  Early Complications and Morbidity of Radical Cystectomy , 2010 .

[31]  W. Otto,et al.  The effect of intra- and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder , 2014, World Journal of Urology.

[32]  D. Sessler,et al.  Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. , 2013, British journal of anaesthesia.

[33]  Mustafa Sarimollaoglu,et al.  Real‐time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry , 2014, Head & neck.

[34]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[35]  A. Degramont,et al.  Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy , 2013, Cancer.

[36]  F. Montorsi,et al.  Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. , 2016, Urologic oncology.

[37]  D. Spahn,et al.  Effects of Allogeneic Red Blood Cell Transfusions on Clinical Outcomes in Patients Undergoing Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis , 2012, Annals of surgery.

[38]  Ondrej Topolcan,et al.  Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. , 2013, Anticancer research.

[39]  D. Buggy,et al.  Can anaesthetic technique effect postoperative outcome? , 2012, Current opinion in anaesthesiology.

[40]  I. Gill,et al.  Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery? , 2016, European urology focus.

[41]  A. Haese*,et al.  No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer , 2015, World Journal of Urology.

[42]  M. Looney,et al.  Reducing Noninfectious Risks of Blood Transfusion , 2011, Anesthesiology.

[43]  P. Austin.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments , 2013, Statistics in medicine.

[44]  Y. Lotan,et al.  Impact of peri‐operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder , 2014, BJU international.

[45]  S. Iyer,et al.  Perioperative Factors Affecting Long-Term Outcomes of 473 Consecutive Patients Undergoing Hepatectomy for Hepatocellular Carcinoma , 2009, Annals of Surgical Oncology.